Technology area: Semiconductors, Circuits & Optics
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Genesis Medtech Japan Co. Ltd. is currently managing 1 pending office action within the Semiconductors, Circuits & Optics technology area. This matter is assigned to LEPISTO, RYAN A, who is the busiest examiner for the portfolio with 1 pending office action. The company's current prosecution is limited to 1 distinct examiner and 1 distinct art unit. The presence of 1 pending office action total indicates a very specific focus for the company's current patenting efforts.
Because the portfolio is handled by only 1 distinct examiner, LEPISTO, RYAN A, the applicant can focus its strategy on the specific requirements of this individual. This concentration within 1 distinct art unit suggests that the company's innovations in the Semiconductors, Circuits & Optics area are currently being evaluated through a single technical lens. This streamlined environment can lead to more predictable prosecution timelines and a more cohesive patent strategy. Practitioners should note that this centralized approach allows for a more efficient use of resources when responding to USPTO communications. The successful resolution of this single pending matter will be a vital step in securing the company's intellectual property in a highly competitive technology sector. By focusing on the feedback from a single examiner, the company can ensure its patenting goals are met with precision.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEPISTO, RYAN A | 1 | 87.7% | +7.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18207435 | CONNECTION MECHANISM AND LOCK MECHANISM USED IN OPTICAL TOMOGRAPHY APPARATUS | LEPISTO, RYAN A | 26d |
| Art Unit | Apps |
|---|---|
| 2874 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18207435 | CONNECTION MECHANISM AND LOCK MECHANISM USED IN OPTICAL TOMOGRAPHY APPARATUS | LEPISTO, RYAN A | 2874 | §102 | Non-Final OA | 26d | Pending | Jun 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGenesis Medtech Japan Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ryan A Lepisto has the most, with 1 of Genesis Medtech Japan Co. Ltd.'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.
